1. Home
  2. ABCL vs DFIN Comparison

ABCL vs DFIN Comparison

Compare ABCL & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.16

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Donnelley Financial Solutions Inc.

DFIN

Donnelley Financial Solutions Inc.

HOLD

Current Price

$39.15

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
DFIN
Founded
2012
1983
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
ABCL
DFIN
Price
$4.16
$39.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$8.40
$61.50
AVG Volume (30 Days)
8.1M
252.0K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
N/A
EPS
N/A
1.27
Revenue
$75,128,000.00
$963,000,000.00
Revenue This Year
N/A
$4.98
Revenue Next Year
$21.85
$3.87
P/E Ratio
N/A
$30.37
Revenue Growth
160.56
N/A
52 Week Low
$1.94
$37.07
52 Week High
$6.52
$66.25

Technical Indicators

Market Signals
Indicator
ABCL
DFIN
Relative Strength Index (RSI) 47.01 28.31
Support Level $3.96 $37.07
Resistance Level $4.84 $50.09
Average True Range (ATR) 0.40 2.18
MACD -0.08 -0.96
Stochastic Oscillator 21.93 8.61

Price Performance

Historical Comparison
ABCL
DFIN

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

Share on Social Networks: